Here are three to note:
Laval, Canada-based Valeant Pharmaceuticals CEO Joe Papa said the company is focusing on increasing its revenue and paying down debt at the New York City-based RBC investor conference.
Caesarea, Israel-based LifeBond is enrolling patients in the United States and Western Europe for its LifeSeal Surgical Sealant’s IDE clinical trial. The gastrointestinal-facing sealant provides reinforcement and minimizes staple-line leakage.
Little Falls, N.J.-based Cantel Medical Corp. agreed to purchase Australia-based distributor CR Kennedy & Co.’s endoscopy business. The distributor’s assets consist of Cantel’s Medivators-branded products, which offer infection prevention solutions for endoscope reprocessing and endoscopy procedures.
More articles on gastroenterology/endoscopy:
Philips’ ElastQ receives FDA 510(k) clearance: 4 key notes
GI leader to know: Dr. Asif Qadri of Athens Digestive Healthcare Associates
Iowa hospital settles botched colonoscopy for $500k: 3 key notes
